1: Huang K, Chen Q, Deng L, Zou Q, Min S. Daurisoline Inhibiting Tumor Angiogenesis and Epithelial-Mesenchymal Transition in Bladder Cancer by Mediating HAKAI Protein Stability. Iran J Pharm Res. 2022 Dec 3;21(1):e129798. doi: 10.5812/ijpr-129798. 2: Wang D, Zhang W, Zhang X, Li M, Wu Q, Li X, Zhao L, Yuan Q, Yu Y, Lu J, Zhao J, Dong Z, Liu K, Jiang Y. Daurisoline suppresses esophageal squamous cell carcinoma growth in vitro and in vivo by targeting MEK1/2 kinase. Mol Carcinog. 2023 Apr;62(4):517-531. doi: 10.1002/mc.23503. Epub 2023 Jan 16. 534:1083-1090. doi: 10.1016/j.bbrc.2020.09.068. Epub 2020 Nov 17. 18(1):248. doi: 10.1186/s13018-023-03717-5.
合成参考文献
摘要:He L, Liu GQ. Interaction of multidrug resistance reversal agents with P-glycoprotein ATPase activity on blood-brain barrier. Acta Pharmacol Sin. 2002 May;23(5):423–9. 参考文献:10.1142/s0192415x1000766x 摘要:Liu QN, Zhang L, Gong PL, Yang XY, Zeng FD. Daurisoline suppressed early afterdepolarizations and inhibited L-type calcium current. Am J Chin Med. 2010;38(1):37–49. doi: 10.1142/s0192415x1000766x.